Navigation Links
Malnutrition as a secondary symptom
Date:10/11/2011

Failure to thrive in childhood is often the result of an underlying organic disease. In the current edition of Deutsches rzteblatt International (Dtsch Arztebl Int 2011; 108[38]: 642-9), Walter Ntzenadel provides an overview of diagnoses and treatment options.

Symptoms such as insufficient weight and loss of weight caused by a lack of nutrients do not affect children in developing countries alone: they also affect 2% to 24% of patients in pediatric hospitals in developed countries. They can therefore impair not only physical development, but also psychomotor and intellectual maturation and defenses against infection. Because of this, early intervention is recommended.

The severity of malnutrition must be determined in order for suitable treatment to be provided. Accurate diagnosis of the underlying disease is also needed, as failure to thrive is often a symptom of a gastrointestinal or neurological disease. Therapy should focus on treatment of the underlying condition. If malnutrition is severe, nutritional treatment may also be used.


'/>"/>

Contact: Dr. Walter Nuetzenadel
w.nuetzenadel@web.de
Deutsches Aerzteblatt International
Source:Eurekalert

Page: 1

Related medicine news :

1. Promising hormone may help reduce malnutrition in gastric cancer patients
2. Childhood malnutrition could weaken brain function in elderly
3. How to detect malnutrition in patients effectively?
4. Water management and malnutrition crucial issues at McGill food conference
5. Malnutrition: A skeleton in the health care closet
6. MARC Coalition Supports Medicare Secondary Payer Enhancement Act (MSPEA)/H.R. 4796
7. Relief Sought for Secondary Parkinsons Symptoms
8. Vanishing bile duct syndrome secondary to anti-retroviral therapy in HIV
9. Urgent steps needed to tackle inadequate support for women with secondary breast cancer
10. Researchers focus on secondary stroke prevention after study reveals room for improvement
11. Parents often wait too long to treat childrens asthma symptoms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... Virginia (PRWEB) , ... September 20, 2017 , ... ... Flex Pure Clinical Plus Coating System for clients that rely on safety and ... the growth of microorganisms. , Silver has been used for centuries for its ...
(Date:9/20/2017)... ... September 20, 2017 , ... Mirror Mirror Beauty Boutique ... Look Awesome This Autumn with CoolSculpting®. Scheduled for Thursday, September 28th, the afternoon ... Mirror Mirror Beauty Boutique is Houston’s largest CoolSculpting provider, holding the ...
(Date:9/20/2017)... ... September 20, 2017 , ... Each year Athletic Trainers from ... Trainers’ Association Annual Clinical Symposium and Expo. New research is revealed, evidence based ... Trainers are acknowledged by their peers with accolades and highly prestigious awards. This ...
(Date:9/20/2017)... ... September 20, 2017 , ... Medicare doesn’t have the authority ... gouging for their prescription drugs, according to a new comparison of drug plans ... our behalf, there’s no consistency in drug pricing among drug plans,” states TSCL’s ...
(Date:9/20/2017)... ... September 20, 2017 , ... “Finn Mouseson”: follows the exciting story ... average life. This mouse sets out on a journey that will show that friends ... the creation of newly published author and illustrator, Melody Gersonde-Mickelson, who has earned a ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... -- Eli Lilly and Company (NYSE: LLY ... more efficiently focus resources on developing new medicines ... reductions, including those from a U.S. voluntary early ... positions. With the streamlining efforts ... $500 million that will begin to be realized ...
(Date:9/7/2017)...   BioLife Solutions , Inc. (NASDAQ: BLFS ... grade cell and tissue hypothermic storage and ... , President and CEO, will be presenting at two investment ... Renshaw 19 th Annual Global Investment Conference on Tuesday, ... time). The conference is being held at the New York ...
(Date:9/6/2017)... Sept. 6, 2017 Eli Lilly and Company ... present new data for galcanezumab and lasmiditan, two investigational ... International Headache Society (IHC) taking place Sept. 7-10 in ... will highlight new, long-term data from an open-label study ... galcanezumab (120 mg and 240 mg) for the prevention ...
Breaking Medicine Technology: